Inventor
Adam Golebiowski
Inventor
Loveland, OH, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C07BGeneral methods of organic chemistry1%
C07CAcyclic or carbocyclic compounds1%
C07KPeptides1%
C12NMicroorganisms or enzymes1%
PatentTitleYear
10,851,099Dipeptide piperidine derivatives202010,538,508Substituted amino triazoles useful as human chitinase inhibitors202010,538,537Inhibitors of arginase and their therapeutic applications202010,391,077Arginase inhibitors and their therapeutic applications201910,329,310Arginase inhibitors and their therapeutic applications201910,214,531Substituted amino triazoles, and methods using same201910,208,020Substituted amino triazoles useful as human chitinase inhibitors20199,994,594Inhibitors of arginase and their therapeutic applications20189,944,624Substituted amino triazoles useful as human chitinase inhibitors20189,611,514'Method for selection of hDIS3 PIN domain inhibitors and use of hDIS3 PIN domain inhibitors for cancer treatment'20179,440,953'Substituted amino triazoles useful as acidic mammalian chitinase inhibitors'20169,266,908'Inhibitors of arginase and their therapeutic applications'20169,040,703'Inhibitors of arginase and their therapeutic applications'20158,354,407'2-anilino-4-(heterocyclic)amino-pyrimidines'20138,158,641'2-anilino-4-aminoalkyleneaminopyrimidines'20127,482,356'Bicyclic pyrazolone cytokine inhibitors'20097,449,474'Tri-substituted ureas as cytokine inhibitors'20087,402,589'Tri-substituted ureas as cytokine inhibitors'20087,319,102'Pyrrolo[2,3-d]pyrimidine cytokine inhibitors'20087,256,196'Purine cytokine inhibitors'20076,872,825'Peptide β-turn mimetic compounds and processes for making them'20056,849,627'6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines'20056,566,357'Spirocyclic-6,7-dihydro-5H-pyrazolo1,2-apyrazol-1-ones which control inflammatory cytokines'20036,291,709'Solid supported synthesis of hydroxamic acids'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2009Patents assigned to PROCTER & GAMBLE (9)· patent assignee history
2001–2009Based in Loveland, OH, US· patent location history
2012–2015Patents assigned to GOLEBIOWSKI ADAM (3)· patent assignee history
2012–2013Patents assigned to BOEHRINGER INGELHEIM INT (2)· patent assignee history
2012–2020Based in Madison, CT, US· patent location history
2015–2020Patents assigned to MARS INC (4)· patent assignee history
2015Based in Branford, CT, US· patent location history
2016–2020Based in McLean, VA, US· patent location history
2017–2019Based in Warsaw, PL· patent location history
2018–2020Patents assigned to ONCOARENDI THERAPEUTICS SA (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROCTER & GAMBLE | 9 | 2001–2009 |
| ONCOARENDI THERAPEUTICS SA | 6 | 2018–2020 |
| MARS INC | 4 | 2015–2020 |
| GOLEBIOWSKI ADAMself | 3 | 2012–2015 |
| BOEHRINGER INGELHEIM INT | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Loveland, OH, US | 9 | 2001–2009 |
| Madison, CT, US | 8 | 2012–2020 |
| McLean, Virginia, US | 3 | 2016–2020 |
| Warsaw, PL | 3 | 2017–2019 |
| Branford, CT, US | 1 | 2015 |